Home › Funds › Kalehua Capital Management LLC › MIST
Kalehua Capital Management LLC position in MIST
MILESTONE PHARMACEUTICALS IN · Health Care
Kalehua Capital Management LLC reported holding 1,651,258 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.08% of its reported portfolio and ranking #17 among its reported holdings. Kalehua Capital Management LLC has disclosed MIST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Kalehua Capital Management LLC's MIST position evolved
Kalehua Capital Management LLC first disclosed a stake in MIST in Q2 2026 at 1,269,237 shares (US$1.7M). Across 2 filings, Kalehua Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,651,258 shares valued at US$1.4M — an increase of 382,021 shares quarter over quarter.. Notable position changes include a 30% increase in Q3 2026 (shares fell 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.27M | $1.70M | New |
| Q3 2026 | 1.65M | $1.43M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIST and 13F data
MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 29 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$8.2M), Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$2.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIST
- Propel Bio Management, LLC 9.45M sh · $8.18M · Q3 2026
- Pavaki Capital Management LLC 9.34M sh · $8.08M · Q3 2026
- Simplify Asset Management Inc. 3.35M sh · $2.90M · Q3 2026
- Lion Point Capital, LP 820.00K sh · $1.10M · Q2 2026
More on Kalehua Capital Management LLC
FAQ
How long has Kalehua Capital Management LLC held MIST?
Kalehua Capital Management LLC has disclosed MIST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Kalehua Capital Management LLC's current position in MIST?
As of Q3 2026, Kalehua Capital Management LLC holds 1.65M shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $1.43M, representing 1.08% of its reported portfolio and ranking #17.
Has Kalehua Capital Management LLC been buying or selling MIST?
In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC increased its position in MIST.
Which other funds hold MIST?
Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Simplify Asset Management Inc., among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.